Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
Tags LILLY DRN Politics Policy
From CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Tags JPMorgan Chase & Co Amazon/com Inc Hospitals
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Novo Nordisk A/S Teva Pharmaceutical Industries Ltd Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Business
From CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Tags Business News Health & Science LILLY DRN
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Tags US: News Pharmaceuticals LILLY DRN
From CNBC.com News
Cramer's Lightning Round: 'I'd be careful' with Novo Nordisk
Tags Market Outlook U/S/ Markets Lemonade Inc
From CNBC.com News
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
Tags 23andMe Holding Co/ Oscar Health Inc Novo Nordisk A/S
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags Health care policy Biotechnology Health care industry
From CNBC.com News
CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?
Tags Market Outlook Asia Markets Boeing Co
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags LILLY DRN Health & Science Companies
From CNBC.com News
Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
Tags Breaking News: Markets Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Tags Roche Holding AG Business AstraZeneca PLC
From CNBC.com News
Europe's economy faces a bumpy ride in 2025. Here are 5 things to watch
Tags Dassault Systemes SE Prices Stock markets
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Tags Social issues Health care industry Science
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags Roche Holding AG Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Tags Amazon/com Inc Business Biotech and Pharmaceuticals
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
Tags Cybersecurity Technology Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags AstraZeneca PLC Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags Business News Pharmaceuticals US: News
From CNBC.com News
Hiccups in ETFs tracking MicroStrategy occurring as bull market fuels trading boom in single-stock funds
Tags Exchange/traded funds Breaking News: Markets Breaking News: Investing
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags US: News Pharmaceuticals Business News
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Novo Nordisk A/S Technology DICK'S Sporting Goods Inc
From CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Tags Business News Pharmaceuticals US: News
From CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Tags Companies Business News LILLY DRN
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags AstraZeneca PLC Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
Tags Science Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Business
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Diabetes Medical research Business News
From CNBC.com News
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
Tickers HIMS LLY NEWS NVO
Tags wegovy Food and Drug Administration News
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.